Alembic Pharmaceuticals Ltd successfully completes USFDA inspection for API-III facility

Alembic Pharmaceuticals Limited has successfully completed the United States Food and Drug Administration (USFDA) inspection for its API-III Facility located at Karakhadi. This was a scheduled GMP inspection and was successfully completed without any Form 483 observation. The inspection was conducted from 17th March, 2025 to 21st March, 2025.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 947.75 as compared to the previous close of Rs. 834.15. The total number of shares traded during the day was 79952 in over 4621 trades.

The stock hit an intraday high of Rs. 976.20 and intraday low of 836.00. The net turnover during the day was Rs. 74849066.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 API3Facility Karakhadi USFDA Inspection